Toxoplasmosis complications and novel therapeutic synergism combination of diclazuril plus atovaquone.
- Citation data:
Frontiers in microbiology, ISSN: 1664-302X, Vol: 5, Issue: SEP, Page: 484
- Publication Year:
- Repository URL:
- Immunology and Microbiology; Medicine; toxoplasmosis; combination; diclazuril; atovaquone; synergism; obesity; Toxoplasma; gastroenteritis; Medicine and Health Sciences
Toxoplasmosis is a major cause of foodborne disease, congenital complication, and morbidity. There is an urgent need for safe and effective therapies to encounter congenital and persisting toxoplasmosis. The hypothesis was: combination diclazuril plus atovaquone to exert a novel therapeutic synergy to prevent toxoplasmosis syndromes.